The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Federal and State Courts Deny Daubert and Kemp Motions and Set Stage for Abilify Trials Over Compulsive Behaviors

Posted on March 16, 2018 by Andrew Findley

The United States District Court for the Northern District of Florida’s Chief Judge M. Casey Rodgers has released a redacted version of its January 22, 2018 order denying summary judgment against plaintiffs’ claims that the drug Abilify caused them to engage in compulsive behaviors. The plaintiffs, led on the issue by the national trial firm Robins Kaplan LLP® with significant contributions from other MDL leadership counsel, defeated defendants’ arguments that the cases lacked a credible scientific basis. The federal court denied defendants’ motion to exclude with respect to plaintiffs’ leading experts, finding “most of plaintiffs’ evidence on general causation – including epidemiology (i.e., Etminan Study), background risk, biological plausibility, disproportionality analyses, in vivo and in vitro studies, voluminous case and adverse event reports (including dose-response, dechallenge and recehallenge events), FDA materials, defendants’ investigative findings, and plaintiffs’ experts Bradford-Hill and weight-of-the-evidence analyses – satisfies Rule 702 and Daubert…” The decision clears the way for a bellwether trial against defendants Bristol-Myers Squibb, Otsuka Pharmaceutical Co. and Otsuka America Pharmaceutical Inc., scheduled for June 2018 in Pensacola.

Robins Kaplan also represents approximately 50 plaintiffs in state court in New Jersey before Judge James DeLuca. On January 24, 2018, Judge DeLuca issued an order denying defendants’ Kemp motions. Judge DeLuca found as well that plaintiffs’ experts had a sound scientific basis for their opinions that Abilify causes compulsive gambling and compulsive behaviors. Defendants have sought permission from the appellate court to file an interlocutory appeal of that decision.

“We’re thankful to the courts for their close attention to this case, and look forward to trying these claims before Florida and New Jersey juries beginning in June,” said Tara Sutton, partner and chair of the Mass Tort practice at Robins Kaplan, which serves as lead counsel to the New Jersey plaintiffs.

Plaintiffs in the 700-plus federal court cases and 50-plus New Jersey cases allege that taking Abilify, a treatment for schizophrenia, bipolar disorder, and depression which is also prescribed off-label, led them to engage in compulsive gambling, compulsive shopping, hypersexuality, and binge eating. Robins Kaplan has also been appointed to the leadership team in the federal multidistrict litigation (MDL), which involves nearly 600 plaintiffs.

In the MDL proceeding, Sutton, who was lead counsel in the Daubert hearing, also serves on the Joint Settlement Committee, Gary Wilson serves as co-lead counsel and serves on the Executive Committee, and Munir Meghjee was named Plaintiffs’ Federal/State Liaison counsel.

The New Jersey litigation is Jonathan Yun v. Bristol-Myers Squibb, et al., pending before Judge James J. DeLuca, and the MDL is In re Abilify (Aripiprazole Products Liability Litigation, MDL no. 2734), pending before the Hon. Chief Judge M. Casey Rodgers.

In addition to Sutton, Wilson, and Meghjee, other Robins Kaplan attorneys representing the plaintiffs in these matters include National Women’s Trial Lawyers Association member Rayna Kessler, Julie Reynolds,  Eric Lindenfeld, and Jason DePauw.

Rodgers Daubert decision redacted public version[2][4][1]

Posted in Blog | Tagged Abilify, Bristol-Myers Squibb, Otsuka Pharmaceutical, ruling

Comments are closed.

News Categories

Subscribe to Blog and VFJ via Email

Enter your email address to subscribe to this blog, the Voice for Justice and receive notifications of new posts by email.

Read about other Top Jury Verdicts

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

The U.S. Department of Justice and U.S. Environmental Protection Agency (EPA) announced today that the United States has[Read More...]
Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Bingen, Wash.-based Insitu, a Boeing subsidiary, has agreed to pay $25 million to settle allegations that it used recycl[Read More...]
Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

DEUTSCHE Bank AG agreed to pay US$130 million to settle criminal and civil charges that it bribed foreign officials and manip[Read More...]
Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing has agreed to pay just over $2.5 billion to resolve a federal charge of “criminal misconduct” for how its [Read More...]
Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

The mass exodus of Texas Attorney General Ken Paxton's top staff over accusations of bribery against their former boss has le[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.